Zacks Investment Research recently raised its forecast for SRAX’s 4Q21 revenues to $10.05mn, representing +122.3% YoY growth Zacks have also upped their fiscal year 2022 revenue forecast to $42.52 million, implying +35% YoY growth SRAX’s…
PlantX Life Inc. is an e-commerce retailer devoted to not only selling plant products, but educating consumers about their effective use and wellness benefits The company has developed a weekly podcast series, YouTube channel videos…
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, has scheduled several industry-specific events for 2022. The company has announced its initial…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, has released a shareholder letter. The letter, from president and CEO Eric A. Adams, provided INM shareholders with a company…
As a significant number of drugs fail to reach the market owing to poor bioavailability, Lexaria Bioscience Corp. (NASDAQ: LEXX) is among those companies exploring different tools and methods to try to solve the problem.…
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is marking key milestones to revolutionize mental health care. Among these, the company recently secured a grant for the first-ever…
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, recently completed the initial shipment of its sugarBEAT(R) continuous glucose monitor (“CGM”)…
FingerMotion (NASDAQ: FNGR), a mobile data and services company with evolving technology and a core competency in mobile payment and recharge platform solutions in China, today announced that it has recently retained the services of…
AnPac Bio-Medical Science (NASDAQ: ANPC), a U.S.- and China-based biotechnology company focused on early cancer screening and detection, announced that its Class III medical device for lung cancer auxiliary diagnosis has passed stringent and rigorous…
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products, today announced that its Mind Naturals skincare brand has launched sales through Walmart.com and Coppel, a nationwide department store in Mexico. According…
USPTO notice marks important milestone in the expansion of CYBN’s intellectual property portfolio Once issued, patent may have opportunity to cover a broad range of claims Anxiety disorders are one of the most common mental…
Growth Capital (NASDAQ: GCAC), a publicly traded special purpose acquisition company listed on Feb. 2, 2021, recently announced its entry into a definitive business combination agreement with Cepton Technologies Inc., a Silicon Valley innovator and…
Flora Growth Corp. is a Canadian cannabis and wellness brand distributor operating from a cultivation base in central Colombia The company’s focus on sustainability guides its efforts to market products that are beneficial to their…
FingerMotion received approval for its application for NASDAQ up-listing, and commenced trading on Tuesday, December 28, 2021, under the company’s current trading symbol, “FNGR” The approval marks a key milestone for the company as it…
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has recently announced that it will no longer have to consolidate the financials…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, today announced that its CEO Eric A. Adams, SVP and General Manager of BayMedica, Shane Johnson, and VP of Commercial…
Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has issued 6,784,812 shares to settle a CAD$5.1 million (US$4.0 million) debt. By settling the debt at…
PlantX President and CEO Lorne Rapkin was recently part of an EDGE Podcast episode hosted by Brandon C. White, an entrepreneur and angel investor Lorne detailed his background and how he joined PlantX The interview…
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has received Independent Review Board (“IRB”) approval for its planned DehydraTECH-CBD human hypertension study HYPER-H21-4; the approval was received earlier than anticipated. The study is…
Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs. Since its founding in 2011, Nemaura set out to develop a…